In April 2025, the FDA announced plans to shift biomedical research for monoclonal antibodies and other medications away from animal testing toward new approaches. One year later, much speculation ...
The Trump administration is redoubling its efforts to phase out animal testing in drug development and seeking to develop new biotechnology methods instead to spur innovation in the pharmaceutical ...
Advances in organ and computer models are raising the prospect that some animal experiments could be eliminated. But there ...
A curated partner ecosystem uniting methodology, technology, and managed services to move life sciences from compliance ...
In 2025, the U.S. Food and Drug Administration finalized guidance on Computer Software Assurance (CSA), explicitly endorsing a risk-based framework for software used in device production and quality ...
39m
Pattern Expands Global Patent Protection for PCI020302 Across U.S., Mexico, Europe, and Australia
Pattern Computer®, Inc. (“Pattern” or “the Company”), the global leader in Pattern Discovery, today announced expanded global intellectual property protection for its investigational cancer therapy ...
Asia's best solutions partner, will participate in NVIDIA GTC for the third consecutive year under the theme "From AI to Action: Physical AI in Motion." Together with ecosystem partners, EDOM will ...
The Atlas will expand known evolutionary genetic diversity by 100x, collecting novel genomic data from over 100 million new ...
Renowned founder and robotics visionary joins AiM at a pivotal growth inflection point —WORCESTER, Mass., March 11, 2026 (GLOBE NEWSWIRE) -- ...
DayOne and Cortical Labs are bringing ‘wetware’ computing to the city-state, using living neurons grown from stem cells to support the demand for AI while addressing sustainability concerns ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results